Huan Yang

Title: Huan Yang - Innovator in Cancer Therapy

Introduction

Huan Yang is a notable inventor based in Millbury, MA (US). He has made significant contributions to the field of cancer therapy through his innovative research and development of novel treatments.

Latest Patents

Huan Yang holds a patent for an invention titled "EpCAM antibody and CAR-T cells." This invention provides EpCAM antibodies with varying affinities and introduces chimeric antigen receptors (CARs) that are specific to EpCAM. The CAR T cells, which comprise human EpCAM scFv with low and sufficient affinity to EpCAM, are designed to avoid targeting healthy tissues that express low levels of EpCAM while effectively targeting tumor tissues with high EpCAM expression. This invention also outlines an adoptive cell therapy method for treating cancer by administering CAR-T cells that bind to cancer cells overexpressing EpCAM, leading to the destruction of these cancer cells.

Career Highlights

Huan Yang is currently associated with Affyimmune Therapeutics, Inc., where he continues to advance his research in cancer therapies. His work is pivotal in developing treatments that can improve patient outcomes in oncology.

Collaborations

Huan collaborates with esteemed colleagues, including Moonsoo Jin and Janusz Puc, who contribute to his research endeavors and the development of innovative cancer therapies.

Conclusion

Huan Yang's contributions to cancer therapy through his patent on EpCAM antibodies and CAR-T cells exemplify his commitment to advancing medical science. His work has the potential to significantly impact the treatment of cancer, offering hope to many patients.